3'-N-Demethyl-3'-N-((4-methylphenyl)sulfonyl)azithromycin(CAS: 612069-31-5)

3'-N-Demethyl-3'-N-((4-methylphenyl)sulfonyl)azithromycin (CAS: 612069-31-5) is subject to various regulatory guidelines including REACH for European Union registration, FDA for pharmaceutical usage, and EPA for environmental protection. It is also regulated under GHS for classification and labeling of chemicals based on their physical and health hazards.

Alternatives to 3'-N-Demethyl-3'-N-((4-methylphenyl)sulfonyl)azithromycin (CAS: 612069-31-5) include other azithromycin derivatives or related macrolides. Common reagents such as 4-methylphenylsulfonyl chloride can be used as a substitute for the specific sulfonyl group in synthesis.

The market for 3'-N-Demethyl-3'-N-((4-methylphenyl)sulfonyl)azithromycin (CAS: 612069-31-5) is driven by ongoing research into its antimicrobial properties. Recent trends indicate increasing interest in developing new azithromycin analogs for enhanced efficacy and reduced resistance. Market demand is also linked to pharmaceutical advancements and regulatory approvals.

Waste containing 3'-N-Demethyl-3'-N-((4-methylphenyl)sulfonyl)azithromycin (CAS: 612069-31-5) should be collected and disposed of according to local and international waste management regulations. Incineration is a common method, but professional waste disposal services or compliance with hazardous waste handling protocols should be followed to ensure environmental safety and regulatory compliance.